A detailed history of Haverford Trust CO transactions in Baxter International Inc stock. As of the latest transaction made, Haverford Trust CO holds 13,458 shares of BAX stock, worth $529,841. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,458
Previous 18,730 28.15%
Holding current value
$529,841
Previous $800,000 43.75%
% of portfolio
0.0%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$32.87 - $43.55 $173,290 - $229,595
-5,272 Reduced 28.15%
13,458 $450,000
Q1 2024

May 02, 2024

SELL
$37.88 - $43.77 $68,184 - $78,786
-1,800 Reduced 8.77%
18,730 $800,000
Q4 2023

Feb 08, 2024

SELL
$31.71 - $38.95 $71,347 - $87,637
-2,250 Reduced 9.88%
20,530 $793,000
Q3 2023

Nov 09, 2023

SELL
$37.32 - $49.29 $550,656 - $727,273
-14,755 Reduced 39.31%
22,780 $859,000
Q2 2023

Aug 08, 2023

SELL
$39.98 - $47.68 $879,120 - $1.05 Million
-21,989 Reduced 36.94%
37,535 $1.71 Million
Q1 2023

May 12, 2023

SELL
$37.58 - $52.57 $61.1 Million - $85.4 Million
-1,625,077 Reduced 96.47%
59,524 $2.41 Million
Q4 2022

Feb 13, 2023

SELL
$49.7 - $57.71 $8.87 Million - $10.3 Million
-178,538 Reduced 9.58%
1,684,601 $85.9 Million
Q3 2022

Nov 14, 2022

BUY
$53.86 - $66.8 $545,709 - $676,817
10,132 Added 0.55%
1,863,139 $100 Million
Q2 2022

Aug 12, 2022

BUY
$63.83 - $80.0 $1.7 Million - $2.13 Million
26,573 Added 1.45%
1,853,007 $119 Million
Q1 2022

May 05, 2022

BUY
$76.85 - $89.45 $4.27 Million - $4.97 Million
55,609 Added 3.14%
1,826,434 $142 Million
Q4 2021

Feb 14, 2022

SELL
$74.57 - $87.19 $1.37 Million - $1.6 Million
-18,323 Reduced 1.02%
1,770,825 $152 Million
Q3 2021

Nov 12, 2021

BUY
$73.77 - $83.61 $1.9 Million - $2.15 Million
25,701 Added 1.46%
1,789,148 $144 Million
Q2 2021

Aug 16, 2021

BUY
$80.5 - $88.01 $131 Million - $143 Million
1,621,489 Added 1142.23%
1,763,447 $142 Million
Q2 2021

Aug 16, 2021

SELL
$80.5 - $88.01 $128 Million - $140 Million
-1,591,628 Reduced 91.81%
141,958 $142 Million
Q1 2021

May 12, 2021

BUY
$76.38 - $86.03 $33.8 Million - $38 Million
442,089 Added 34.23%
1,733,586 $146 Million
Q4 2020

Feb 05, 2021

BUY
$75.39 - $82.36 $4.22 Million - $4.62 Million
56,038 Added 4.54%
1,291,497 $104 Million
Q3 2020

Nov 10, 2020

BUY
$78.33 - $90.73 $3 Million - $3.47 Million
38,277 Added 3.2%
1,235,459 $99.4 Million
Q2 2020

Aug 13, 2020

BUY
$78.66 - $94.14 $4.44 Million - $5.32 Million
56,479 Added 4.95%
1,197,182 $103 Million
Q1 2020

May 11, 2020

BUY
$71.57 - $93.3 $1.04 Million - $1.35 Million
14,510 Added 1.29%
1,140,703 $92.6 Million
Q4 2019

Feb 10, 2020

SELL
$76.7 - $88.45 $134,915 - $155,583
-1,759 Reduced 0.16%
1,126,193 $94.2 Million
Q3 2019

Nov 04, 2019

BUY
$81.4 - $89.78 $567,683 - $626,125
6,974 Added 0.62%
1,127,952 $98.7 Million
Q2 2019

Aug 13, 2019

BUY
$73.44 - $82.41 $802,772 - $900,823
10,931 Added 0.98%
1,120,978 $91.8 Million
Q1 2019

May 09, 2019

BUY
$64.48 - $81.31 $1.31 Million - $1.65 Million
20,239 Added 1.86%
1,110,047 $90.3 Million
Q4 2018

Feb 12, 2019

BUY
$61.45 - $77.8 $764,007 - $967,287
12,433 Added 1.15%
1,089,808 $71.7 Million
Q3 2018

Nov 08, 2018

SELL
$70.71 - $77.75 $447,806 - $492,390
-6,333 Reduced 0.58%
1,077,375 $83.1 Million
Q2 2018

Aug 10, 2018

SELL
$63.43 - $75.41 $938,890 - $1.12 Million
-14,802 Reduced 1.35%
1,083,708 $80 Million
Q1 2018

May 09, 2018

SELL
$62.56 - $72.26 $471,702 - $544,840
-7,540 Reduced 0.68%
1,098,510 $71.4 Million
Q4 2017

Feb 13, 2018

SELL
$61.45 - $66.05 $852,188 - $915,981
-13,868 Reduced 1.24%
1,106,050 $71.5 Million
Q3 2017

Nov 09, 2017

BUY
$59.5 - $64.61 $71,995 - $78,178
1,210 Added 0.11%
1,119,918 $70.3 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,118,708
1,118,708 $67.7 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $19.8B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Haverford Trust CO Portfolio

Follow Haverford Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Haverford Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Haverford Trust CO with notifications on news.